Compassionate Use Program With Brivaracetam for the Treatment of Patients With Epilepsy

Summary

This Compassionate Use Program (CUP) is setup to provide study patients with continuous access to Brivaracetam (BRV) for the time period between closures of the long-term follow up studies N01125, N01199, N01372, N01379, and N01315 and when BRV is commercially available.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications